Secobarbital Sodium

司可巴比妥钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSecobarbital Sodium
Drug Alias NameQuinalbarbitone Sodium丙烯戊巴比妥钠secobarbitalsecobarbitalumSeconal sodium +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSedationSleep Initiation and Maintenance DisordersAnesthesia
Global Approved IndicationsSedationSleep Initiation and Maintenance DisordersAnesthesia
Approved Indications in ChinaSleep Initiation and Maintenance Disorders
Original Approved Country/TerritoryCanada
Original Approved Date1939/01/01
Country/TerritoryCanadaUnited StatesMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHarbin Pharmaceutical Group Co Ltd General Pharm Factory
Inactive CompaniesEli Lilly And CompanyPharmascience Inc
Active IndicationsSedationSleep Initiation and Maintenance DisordersAnesthesia
Inactive IndicationsN/A

Other Information

ATC CodeN05CA06
Related LinksWikipediaDrugBankKEGG